LRMR
Price
$1.91
Change
-$0.07 (-3.54%)
Updated
Apr 4, 02:43 PM (EDT)
Capitalization
126.13M
34 days until earnings call
XFOR
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Apr 4, 04:24 PM (EDT)
Capitalization
35.81M
34 days until earnings call
Ad is loading...

LRMR vs XFOR

Header iconLRMR vs XFOR Comparison
Open Charts LRMR vs XFORBanner chart's image
Larimar Therapeutics
Price$1.91
Change-$0.07 (-3.54%)
Volume$200
Capitalization126.13M
X4 Pharmaceuticals
Price$0.20
Change-$0.01 (-4.76%)
Volume$700
Capitalization35.81M
LRMR vs XFOR Comparison Chart
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. XFOR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and XFOR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (LRMR: $1.98 vs. XFOR: $0.21)
Brand notoriety: LRMR and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 86% vs. XFOR: 42%
Market capitalization -- LRMR: $126.13M vs. XFOR: $35.81M
LRMR [@Biotechnology] is valued at $126.13M. XFOR’s [@Biotechnology] market capitalization is $35.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileXFOR’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • XFOR’s FA Score: 0 green, 5 red.
According to our system of comparison, both LRMR and XFOR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 4 TA indicator(s) are bullish while XFOR’s TA Score has 4 bullish TA indicator(s).

  • LRMR’s TA Score: 4 bullish, 3 bearish.
  • XFOR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both LRMR and XFOR are a good buy in the short-term.

Price Growth

LRMR (@Biotechnology) experienced а -17.50% price change this week, while XFOR (@Biotechnology) price change was -22.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

LRMR is expected to report earnings on May 08, 2025.

XFOR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($126M) has a higher market cap than XFOR($35.8M). LRMR YTD gains are higher at: -48.837 vs. XFOR (-71.374). XFOR has higher annual earnings (EBITDA): -7.74M vs. LRMR (-73.44M). LRMR has more cash in the bank: 204M vs. XFOR (135M). LRMR has less debt than XFOR: LRMR (5.36M) vs XFOR (78.2M). XFOR has higher revenues than LRMR: XFOR (1.12M) vs LRMR (0).
LRMRXFORLRMR / XFOR
Capitalization126M35.8M352%
EBITDA-73.44M-7.74M949%
Gain YTD-48.837-71.37468%
P/E RatioN/A3.10-
Revenue01.12M-
Total Cash204M135M151%
Total Debt5.36M78.2M7%
FUNDAMENTALS RATINGS
LRMR vs XFOR: Fundamental Ratings
LRMR
XFOR
OUTLOOK RATING
1..100
648
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
9497
P/E GROWTH RATING
1..100
10085
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (19) in the null industry is in the same range as XFOR (42) in the Biotechnology industry. This means that LRMR’s stock grew similarly to XFOR’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as XFOR (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to XFOR’s over the last 12 months.

XFOR's SMR Rating (96) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that XFOR’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (94) in the null industry is in the same range as XFOR (97) in the Biotechnology industry. This means that LRMR’s stock grew similarly to XFOR’s over the last 12 months.

XFOR's P/E Growth Rating (85) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that XFOR’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMRXFOR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
87%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRWAX22.03N/A
N/A
Transamerica International Equity A
RLEOX10.76N/A
N/A
Lazard Emerging Markets Core Equity R6
GMOUX27.44N/A
N/A
GMO International Equity I
WBVRX27.65N/A
N/A
William Blair Small Cap Value R6
AABFX13.55-0.22
-1.60%
Thrivent Dynamic Allocation A

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-10.00%
SVRA - LRMR
45%
Loosely correlated
-3.65%
IMNM - LRMR
44%
Loosely correlated
-7.00%
ACLX - LRMR
42%
Loosely correlated
-7.12%
ERAS - LRMR
41%
Loosely correlated
-3.97%
IDYA - LRMR
41%
Loosely correlated
-4.77%
More